acute lymphoblastic leukemia

Showing 51 - 75 of 493

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Lymphoblastic Leukemia Trial in Al Kharj (Dose-graded aerobic exercises, Traditional physical rehabilitation)

Completed
  • Acute Lymphoblastic Leukemia
  • Dose-graded aerobic exercises
  • Traditional physical rehabilitation
  • Al Kharj, Riyadh, Saudi Arabia
    Ragab K. Elnaggar
Dec 24, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total

Active, not recruiting
  • Acute Myeloid Leukemia
  • +17 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023

Lymphoid Leukemia, Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Tampa (CPX-351)

Active, not recruiting
  • Lymphoid Leukemia
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Dec 30, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +7 more
  • Blinatumomab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Multiple Myeloma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Charlottesville (Pre-biotic foods/drinks)

Completed
  • Multiple Myeloma
  • +11 more
  • Pre-biotic foods/drinks
  • Charlottesville, Virginia
    University of Virginia
Jan 2, 2023

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

Active, not recruiting
  • Acute Biphenotypic Leukemia
  • +18 more
  • Aurora, Colorado
  • +2 more
Dec 28, 2022

Pediatric Acute Lymphoblastic Leukemia in the United States

Recruiting
  • Acute Lymphoblastic Leukemia
  • Electronic Health Record Review
  • +2 more
  • Oakland, California
  • +30 more
Dec 28, 2022

Acute Lymphoblastic Leukemia, Immune System Diseases, Immunoproliferative Disorders Trial in Chapel Hill (iC9-CAR19 cells,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • iC9-CAR19 cells
  • +3 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Dec 21, 2022

Acute Lymphoblastic Leukemia Trial in Suzhou (cladribine, cytarabine,venetoclax)

Recruiting
  • Acute Lymphoblastic Leukemia
  • cladribine, cytarabine,venetoclax
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 22, 2022

Acute Lymphoblastic Leukemia Trial in United States (Calaspargase pegol (S95015))

Recruiting
  • Acute Lymphoblastic Leukemia
  • Calaspargase pegol (S95015)
  • Scottsdale, Arizona
  • +14 more
Dec 13, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +12 more
  • Tucson, Arizona
    The University of Arizona Cancer Center
Dec 13, 2022

Severe Toxicity Free Survival Following Childhood Acute

Recruiting
  • Acute Lymphoblastic Leukemia
    • Copenhagen, Denmark
      Kjeld Schmiegelow
    Dec 9, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +6 more
    • Duarte, California
      City of Hope Medical Center
    Dec 8, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +11 more
    • Duarte, California
      City of Hope Medical Center
    Dec 8, 2022

    Acute Lymphoblastic Leukemia, Lymphoma, Multiple Myeloma Trial in Taiyuan (CAR-T Autologous T cell injection)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • CAR-T Autologous T cell injection
    • Taiyuan, Shanxi, China
      Shanxi Bethune Hospital
    Dec 2, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +16 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 1, 2022

    Acute Lymphoblastic Leukemia Trial in Ann Arbor (Dasatinib, Ponatinib, Berlin-Frankfurt-Münster Chemotherapy)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Nov 28, 2022

    Acute Lymphoblastic Leukemia Trial in Sanhe (CAR-NK-CD19 Cells)

    Completed
    • Acute Lymphoblastic Leukemia
    • CAR-NK-CD19 Cells
    • Sanhe, Hebei, China
      Hebei Yanda Ludaopei Hospital
    Nov 24, 2022

    Pharmacogenomics of Asparaginase Induced Hepatotoxicity

    Suspended
    • Acute Lymphoblastic Leukemia
    • Biospecimen Collection
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Nov 18, 2022

    Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Positive Trial in New York (Blinatumomab, dasatinib, dexamethasone)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Philadelphia Chromosome-Positive
    • Blinatumomab
    • +3 more
    • New York, New York
    • +1 more
    Nov 10, 2022

    Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,

    Terminated
    • Hematopoietic Stem Cell Transplantation
    • +4 more
    • Duarte, California
    • +3 more
    Oct 18, 2022

    Acute Lymphoblastic Leukemia, Hyperbilirubinemia Trial in Houston (Levocarnitine, Vitamin B Complex)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Hyperbilirubinemia
    • Levocarnitine
    • Vitamin B Complex
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 7, 2022

    l Parenting Skills As A Novel Target for Improving Pediatric

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Survey Administration
    • Buffalo, New York
      Roswell Park Cancer Institute
    Nov 8, 2022

    Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

    Completed
    • Myeloproliferative Disorders
    • +4 more
    • T-cell replete PBPC allograft
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Oct 12, 2022